TW200607863A - Immune modulating compounds from fungi - Google Patents

Immune modulating compounds from fungi

Info

Publication number
TW200607863A
TW200607863A TW094124419A TW94124419A TW200607863A TW 200607863 A TW200607863 A TW 200607863A TW 094124419 A TW094124419 A TW 094124419A TW 94124419 A TW94124419 A TW 94124419A TW 200607863 A TW200607863 A TW 200607863A
Authority
TW
Taiwan
Prior art keywords
compositions
fungi
immune modulating
modulating compounds
immune
Prior art date
Application number
TW094124419A
Other languages
English (en)
Chinese (zh)
Inventor
Bjorn Kristiansen
Original Assignee
Medimush As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/892,393 external-priority patent/US7514085B2/en
Application filed by Medimush As filed Critical Medimush As
Publication of TW200607863A publication Critical patent/TW200607863A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/071—Agaricus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
TW094124419A 2004-07-16 2005-07-19 Immune modulating compounds from fungi TW200607863A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US10/892,393 US7514085B2 (en) 2004-07-16 2004-07-16 Immune modulating compounds from fungi
US69048205P 2005-06-15 2005-06-15
US69047705P 2005-06-15 2005-06-15
US69049605P 2005-06-15 2005-06-15
DKPA200500880 2005-06-15
DKPA200500881 2005-06-15
DKPA200500882 2005-06-15

Publications (1)

Publication Number Publication Date
TW200607863A true TW200607863A (en) 2006-03-01

Family

ID=35414957

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094124419A TW200607863A (en) 2004-07-16 2005-07-19 Immune modulating compounds from fungi

Country Status (8)

Country Link
EP (1) EP1774012A2 (enExample)
JP (3) JP2008525311A (enExample)
KR (1) KR20070057803A (enExample)
AU (1) AU2005263329A1 (enExample)
CA (1) CA2574060C (enExample)
IL (1) IL180713A0 (enExample)
TW (1) TW200607863A (enExample)
WO (1) WO2006007848A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI673058B (zh) * 2018-07-20 2019-10-01 金穎生物科技股份有限公司 靈芝複合多醣體組成物

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20014256D0 (no) 2001-09-03 2001-09-03 Bjoern Kristiansen Fremstilling av immunstimulerende forbindelse
US7514085B2 (en) 2004-07-16 2009-04-07 Medimush A/S Immune modulating compounds from fungi
US9072776B2 (en) 2005-06-15 2015-07-07 Glycanova As Anti-cancer combination treatment and kit-of-parts
US20090005340A1 (en) * 2005-06-15 2009-01-01 Medimush A/S Bioactive Agents Produced By Submerged Cultivation of a Basidiomycete Cell
KR100825119B1 (ko) * 2006-12-29 2008-04-25 영남대학교 산학협력단 간질환의 예방 또는 치료용 약학조성물
US20120058240A1 (en) * 2009-05-15 2012-03-08 Her Majesty The Queen In Right Of The Province Of Nova Scotia, As Represented By The Nova Scotia Agr Stable functional beverage compositions and methods of making same
WO2015083982A1 (ko) * 2013-12-06 2015-06-11 한명순 설사 예방 및 개선용 조성물 및 이를 이용한 경구용 주사기 패키지
KR101695488B1 (ko) * 2013-12-06 2017-01-23 한명순 설사 예방 및 개선용 조성물 및 이를 이용한 경구용 주사기 패키지
CN107613997A (zh) 2015-01-18 2018-01-19 加维什-加利里生物应用有限公司 食用真菌的富含维生素d的提取物、和其组合物、和它们在治疗免疫相关失调中的应用
US20200222536A1 (en) * 2016-05-23 2020-07-16 Orphaderm Limited Biophotonic compositions comprising a fungal-derived chromophore
KR20180093725A (ko) 2017-02-14 2018-08-22 강원대학교산학협력단 렌티난을 함유하는 패혈증의 치료 또는 개선용 약학적 조성물
CN108410944A (zh) * 2018-06-05 2018-08-17 郑州安图生物工程股份有限公司 一种检测艰难梭菌用培养基及其制备方法
CN110403962A (zh) * 2019-09-04 2019-11-05 湖南宇山玉月农业科技有限公司 一种真菌植物在防治鸡坏死性肠炎的应用
CN110656053B (zh) * 2019-11-01 2021-04-13 广东省微生物研究所（广东省微生物分析检测中心） 一种鳞伞属新菌种及其人工栽培方法和用途
FI130808B1 (en) * 2021-02-19 2024-03-27 Natural Resources Inst Finland Luke Fungi-derived composition, its production process and uses
IT202100029000A1 (it) 2021-11-16 2023-05-16 C I A M S R L Composizioni immunostimolanti per animali da compagnia
WO2023168023A1 (en) 2022-03-04 2023-09-07 Reset Pharmaceuticals, Inc. Co-crystals or salts comprising psilocin
CN118453669B (zh) * 2023-07-21 2026-06-26 陕西中医药大学 蜜环菌在制备防治骨代谢或骨质疏松症药物中的应用及蜜环菌制剂
CN118267401B (zh) * 2024-03-28 2024-10-18 吉林农业大学 一种银耳蒂头多糖粪菌物及其在结肠炎中的应用
CN118325993B (zh) * 2024-04-16 2024-11-15 吉林农业大学 一种姬松茸活性肽及其制备方法和应用
CN118546801B (zh) * 2024-07-26 2024-10-01 烟台欣和企业食品有限公司 一株布拉迪酵母菌及其应用
CN121489974A (zh) * 2025-12-08 2026-02-10 成都赛迪科生物科技有限公司 L-β-半乳葡聚糖在抗阴道炎方面的用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1572074A (en) * 1977-03-30 1980-07-23 Kirin Seagram Ltd Chemotherapeutic substances and methods of manufacturing same
JPS54148702A (en) * 1978-05-12 1979-11-21 Kirin Brewery Kss22b
JPS5653101A (en) * 1979-09-21 1981-05-12 Kirin Brewery Co Ltd Polysaccharide ks-2-d and its preparation
JPH0757761B2 (ja) * 1984-03-08 1995-06-21 株式会社林原生物化学研究所 β−グルカンとその製造方法及び用途
EP0292601A1 (en) * 1987-05-14 1988-11-30 Noda Shokukin Kogyo Co., Ltd. Anti aids drug extracted from lentinus edodes
FR2631829B1 (fr) * 1988-05-30 1992-04-03 Pasteur Institut Exopolysaccharides fongiques ayant une activite immunostimulante, leur procede d'obtention et composition therapeutique les contenant
JPH0725802B2 (ja) * 1988-11-28 1995-03-22 味の素株式会社 カードランまたはレンチナンの硫酸エステルまたはその塩の製造方法
JP3522772B2 (ja) * 1991-05-21 2004-04-26 台糖株式会社 ワクチンの免疫効果増強剤
JP3651697B2 (ja) * 1995-03-24 2005-05-25 株式会社アミノアップ化学 新規多糖体物質
CN1069650C (zh) * 1995-12-29 2001-08-15 中国科学院上海药物研究所 香菇多糖的分离纯化方法
AU6261999A (en) * 1998-09-25 2000-04-17 Collaborative Group, Ltd., The Very high molecular weight beta-glucans
NO20014256D0 (no) * 2001-09-03 2001-09-03 Bjoern Kristiansen Fremstilling av immunstimulerende forbindelse
JP5300195B2 (ja) * 2003-09-08 2013-09-25 ジェニオウス バイオメド インターナショナル インコーポレイテッド 癌治療のための植物性薬品抽出物の組成物

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI673058B (zh) * 2018-07-20 2019-10-01 金穎生物科技股份有限公司 靈芝複合多醣體組成物
US11191793B2 (en) 2018-07-20 2021-12-07 Geneferm Biotechnology Co., Ltd. Ganoderma lucidum polysaccharides composite composition

Also Published As

Publication number Publication date
CA2574060A1 (en) 2006-01-26
IL180713A0 (en) 2007-06-03
WO2006007848A2 (en) 2006-01-26
CA2574060C (en) 2019-06-25
JP2014005307A (ja) 2014-01-16
JP5502830B2 (ja) 2014-05-28
EP1774012A2 (en) 2007-04-18
JP5926226B2 (ja) 2016-05-25
AU2005263329A1 (en) 2006-01-26
KR20070057803A (ko) 2007-06-07
WO2006007848A3 (en) 2006-02-23
JP2008525311A (ja) 2008-07-17
JP2012017347A (ja) 2012-01-26

Similar Documents

Publication Publication Date Title
WO2006007848A3 (en) Immune modulating compounds from fungi
HUS2100051I1 (hu) Kompozíciók és eljárások sejtproliferációs rendellenességek kezelésére
WO2021007428A3 (en) Molecules, compositions and methods for treatment of cancer
TW200720256A (en) IL-12 modulatory compounds
TW200514776A (en) Aminotriazole compounds useful as inhibitors of protein kinases
WO2006053227A3 (en) Il-12 modulatory compounds
MXPA06011327A (es) Azaindoles utiles como inhibidores de jak y otras proteinas cinasas.
WO2004043361A3 (en) Compositions and methods for the treatment of natural killer cell related diseases
PL1682530T3 (pl) Podstawione pirolo-indole jako inhibitory PAI-1
MX2009005455A (es) (r)-n-estereoisomeros de analogos de 7,8-saturados-4,5 epoxi-morfinano.
MY161991A (en) Proteasome inhibitors
SG10201405377XA (en) Compositions and methods for antibodies targeting complement protein c5
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
MX2010006378A (es) Moduladores de gamma secretasa.
WO2003027094A3 (en) Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
WO2002102235A3 (en) Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
IL144830A0 (en) Ribosomes structure and protein synthesis inhibitors
WO2008061108A3 (en) Phthalazine derivatives
TW200621721A (en) Methods of preparing indazole compounds
PL1668001T3 (pl) Podstawione heteroarylobenzofuranowe kwasy
TW200630090A (en) Triazoles useful as inhibitors of protein kinases
IL185539A0 (en) Hydrazinocarbonyl-thieno[2,3-c]pyrazoles, preparation method compositions containing same and use
GB0320020D0 (en) Improved formulation for providing an enteric coating material
DE10193689D2 (de) Retardpartikeldispersion
WO2004052236A3 (en) Methods and compositions for treatment of otitis media